Pharmacological stabilization of mast cells abrogates late thrombotic events induced by diesel exhaust particles in hamsters

Circulation

Volumn 110, Issue 12, 2004, Pages 1670-1677

  Nemmar, Abderrahim ^a   Hoet, Peter H M ^a   Vermylen, Jos ^b   Nemery, Benoit ^a   Hoylaerts, Marc F ^b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Air pollution; Lung; Respiration; Thrombosis

Indexed keywords

CROMOGLYCATE DISODIUM; DEXAMETHASONE; HISTAMINE;

AIR POLLUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BASOPHIL; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; ENDOTHELIUM INJURY; EXHAUST GAS; FEMALE; FEMORAL VEIN; HAMSTER; HEART INFARCTION; HISTAMINE RELEASE; LUNG LAVAGE; MALE; MAST CELL; MAST CELL DEGRANULATION; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; THROMBOGENICITY; THROMBOSIS;

AIR POLLUTANTS; ANIMALS; ANTI-INFLAMMATORY AGENTS; BRONCHOALVEOLAR LAVAGE FLUID; CRICETINAE; CROMOLYN SODIUM; CYTOPLASMIC GRANULES; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HISTAMINE; HISTAMINE RELEASE; INSTILLATION, DRUG; LUNG; MALE; MAST CELLS; MESOCRICETUS; MICROSCOPY, VIDEO; ORGAN SPECIFICITY; PARTICLE SIZE; PLATELET AGGREGATION; PNEUMONIA; POLYSTYRENES; THROMBOSIS; TRACHEA; VASCULITIS; VEHICLE EMISSIONS; VON WILLEBRAND FACTOR;

EID: 4644288256     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000142053.13921.21     Document Type: Article

References (54)

1. Black J. The role of mast cells in the pathophysiology of asthma. N Engl J Med. 2002;346:1742-1743.
2. Ginsburg R, Bristow MR, Davis K. Receptor mechanisms in the human epicardial coronary artery: heterogeneous pharmacological response to histamine and carbachol. Circ Res. 1984;55:416-421.
3. Li Y, Chi L, Stechschulte DJ, et al. Histamine-induced production of interleukin-6 and interleukin-8 by human coronary artery endothelial cells is enhanced by endotoxin and tumor necrosis factor-alpha. Microvasc Res. 2001;61:253-262.
4. Asako H, Kurose I, Wolf R, et al. Role of H1 receptors and P-selectin in histamine-induced leukocyte rolling and adhesion in postcapillary venules. J Clin Invest. 1994;93:1508-1515.
5. Eppihimer MJ, Wolitzky B, Anderson DC, et al. Heterogeneity of expression of E- and P-selectins in vivo. Circ Res. 1996;79:560-569.
6. Miyazawa N, Watanabe S, Matsuda A, et al. Role of histamine H1 and H2 receptor antagonists in the prevention of intimal thickening. Eur J Pharmacol. 1998;362:53-59.
7. Masini E, Di Bello MG, Raspanti S, et al. The role of histamine in platelet aggregation by physiological and immunological stimuli. Inflamm Res. 1998; 47:211-220.
8. Saxena SP, Brandes LJ, Becker AB, et al. Histamine is an intracellular messenger mediating platelet aggregation. Science. 1989;243:1596-1599.
9. Shah BH, Lashari I, Rana S, et al. Synergistic interaction of adrenaline and histamine in human platelet aggregation is mediated through activation of phospholipase, map kinase and cyclo-oxygenase pathways. Pharmacol Res. 2000;42:479-483.
10. Benbarek H, Mouithys-Mickalad A, Deby-Dupont G, et al. High concentrations of histamine stimulate equine polymorphonuclear neutrophils to produce reactive oxygen species. Inflamm Res. 1999;48:594-601.
11. Elenkov IJ, Webster E, Papanicolaou DA, et al. Histamine potently suppresses human IL-12 and stimulates IL-10 production via H2 receptors. J Immunol. 1998;161:2586-2593.
12. Clark RA, Sandler JA, Gallin JI, et al. Histamine modulation of eosinophil migration. J Immunol. 1977;118:137-145.
13. Pekkanen J, Peters A, Hoek G, et al. Particulate air pollution and risk of ST-segment depression during repeated submaximal exercise tests among subjects with coronary heart disease: the Exposure and Risk Assessment for Fine and Ultrafine Particles in Ambient Air (ULTRA) study. Circulation. 2002;106:933-938.
14. Peters A, Dockery DW, Muller JE, et al. Increased paniculate air pollution and the triggering of myocardial infarction. Circulation. 2001;103: 2810-2815.
15. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation. 2001;104:365-372.
16. Ware JH. Particulate air pollution and mortality-clearing the air. N Engl J Med. 2000;343:1798-1799.
17. Zaca F, Benassi MS, Ghinelli M, et al. Myocardial infarction and histamine release. Agents Actions. 1986;18:258-261.
18. Clejan S, Japa S, Clemetson C, et al. Blood histamine is associated with coronary artery disease, cardiac events and severity of inflammation and atherosclerosis. J Cell Mol Med. 2002;6:583-592.
19. Laine P, Kaartinen M, Penttila A, et al. Association between myocardial infarction and the mast cells in the adventitia of the infarct-related coronary artery. Circulation. 1999;99:361-369.
20. Diaz-Sanchez D, Penichet-Garcia M, Saxon A. Diesel exhaust particles directly induce activated mast cells to degranulate and increase histamine levels and symptom severity. J Allergy Clin Immunol. 2000;106:1140-1146.
21. Devouassoux G, Saxon A, Metcalfe DD, et al. Chemical constituents of diesel exhaust particles induce IL-4 production and histamine release by human basophils. J Allergy Clin Immunol. 2002;109:847-853.
22. Gilliland FD, Li YF, Saxon A, et al. Effect of glutathlone-S-transferase M1 and P1 genotypes on xenoblotic enhancement of allergic responses: randomised, placebo-controlled crossover study. Lancet. 2004;363:119-125.
23. Salvi S, Blomberg A, Rudell B, et al. Acute inflammatory responses in the airways and peripheral blood after short-term exposure to diesel exhaust in healthy human volunteers. Am J Respir Crit Care Med. 1999;159:702-709.
24. Nemmar A, Hoet PH, Dinsdale D, et al. Diesel exhaust particles in lung acutely enhance experimental peripheral thrombosis. Circulation. 2003;107: 1202-1208.
25. Nemmar A, Nemery B, Hoet PH, et al. Pulmonary inflammation and thrombogenicity caused by diesel particles in hamsters: role of histamine. Am J Respir Crit Care Med. 2003;168:1366-1372.
26. Nemmar A, Hoylaerts MF, Hoet PHM, et al. Ultrafine particles affect experimental thrombosis in an in vivo hamster model. Am J Respir Crit Care Med. 2002;166:998-1004.
27. Kawasaki T, Kaida T, Arnout J, et al. A new animal model of thrombophilia confirms that high plasma factor VIII levels are thrombogenic. Thromb Haemost. 1999;81:306-311.
28. Yamamoto H, Vreys I, Stassen JM, et al. Antagonism of vWF inhibits both injury induced arterial and venous thrombosis in the hamster. Thromb Haemost. 1998;79:202-210.
29. Yu CK, Chen CL. Activation of mast cells is essential for development of house dust mite Dermatophagoides farinae-induced allergic airway inflammation in mice. J Immunol. 2003;171:3808-3815.
30. Kundu SK, Heilmann EJ, Sio R, et al. Description of an in vitro platelet function analyzer-PFA-100. Semin Thromb Hemost. 1995;21(suppl 2):106-112.
31. Peters A, Liu E, Verrier RL, et al. Air pollution and incidence of cardiac arrhythmia. Epidemiology. 2000;11:11-17.
32. Schwartz J, Morris R. Air pollution and hospital admissions for cardiovascular disease in Detroit, Michigan. Am J Epidemiol. 1995;142:23-35.
33. Zanobetti A, Schwartz J. Cardiovascular damage by airborne particles: are diabetics more susceptible? Epidemiology. 2002;13:588-592.
34. Nemmar A, Hoet PH, Vanquickenborne B, et al. Passage of inhaled particles into the blood circulation in humans. Circulation. 2002;105:411-414.
35. Nemmar A, Vanbilloen H, Hoylaerts MF, et al. Passage of intratracheally instilled ultrafine particles from the lung into the systemic circulation in hamster. Am J Respir Crit Care Med. 2001;164:1665-1668.
36. Nemmar A, Hoylaerts M, Hoet PH, et al. Size effect of intratracheally instilled ultrafine particles on pulmonary inflammation and vascular thrombosis. Toxicol Appl Pharmacol. 2003;186:38-45.
37. Oberdorster G, Sharp Z, Atudorei V, et al. Extrapulmonary translocation of ultrafine carbon particle following whole-body inhalation exposure of rats. J Toxicol Environ Health A. 2002;65:1531-1543.
38. Avital A, Shapiro E, Doviner V, et al. Polystyrene microspheres as a specific marker for the diagnosis of aspiration in hamsters. Am J Respir Cell Mol Biol. 2002;27:511-514.
39. Ferin J, Oberdorster G, Penney DP. Pulmonary retention of ultrafine and fine particles in rats. Am J Respir Cell Mol Biol. 1992;6:535-542.
40. Collins PW, Macey MG, Cahill MR, et al. von Willebrand factor release and P-selectin expression is stimulated by thrombin and trypsin but not IL-1 in cultured human endothelial cells. Thromb Haemost. 1993;70:346-350.
41. Blann AD. Associations of von Willebrand factor with age, sex and other risk factors for atherosclerosis. Thromb Haemost. 1994;71:528-529.
42. Columbo M, Casolaro V, Warner JA, et al. The mechanism of mediator release from human basophils induced by platelet-activating factor. J Immunol. 1990;145:3855-3861.
43. Columbo M, Horowitz EW, Kagey-Sobotka A, et al. Histamine release from human basophils induced by platelet activating factor: the role of extracellular calcium, interleukin-3, and granulocyte-macrophage colony-stimulating factor. J Allergy Clin Immunol. 1995;95:565-573.
44. Barnes PJ. Inhaled glucocorticoids for asthma. N Engl J Med. 1995;332: 868-875.
45. McGregor AM. Immunoendocrine interactions and autoimmunity. N Engl J Med. 1990;322:1739-1741.
46. Hafezi-Moghadam A, Simoncini T, Yang E, et al. Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase. Nat Med. 2002;8:473-479.
47. Daeron M, Sterk AR, Hirata F, et al. Biochemical analysis of glucocorticoid-induced inhibition of IgE-mediated histamine release from mouse mast cells. J Immunol. 1982;129:1212-1218.
48. Marquardt DL, Wasserman SI. Modulation of rat serosal mast cell biochemistry by in vivo dexamethasone administration. J Immunol. 1983;131: 934-939.
49. Smith SJ, Piliponsky AM, Rosenhead F, et al. Dexamethasone inhibits maturation, cytokine production and Fc epsilon RI expression of human cord blood-derived mast cells. Clin Exp Allergy. 2002;32:906-913.
50. Schleimer RP, MacGlashan DW Jr, Gillespie E, et al. Inhibition of basophil histamine release by anti-inflammatory steroids, II: studies on the mechanism of action. J Immunol. 1982;129:1632-1636.
51. Sacks M, Gordon J, Bylander J, et al. Silica-induced pulmonary inflammation in rats: activation of NF-kappa B and its suppression by dexamethasone. Biochem Biophys Res Commun. 1998;253:181-184.
52. Volpe BT, Lin W, Thrall RS. Effect of intratracheal dexamethasone on oleic acid-induced lung injury in the rat. Chest. 1994;106:583-587.
53. Barnes PJ. Molecular mechanisms of corticosteroids in allergic diseases. Allergy. 2001;56:928-936.
54. Holgate ST. The role of mast cells and basophils in inflammation. Clin Exp Allergy. 2000;30:28-32.